- Abacavir Therapy and HLA-B*57:01 Genotype
- Allopurinol Therapy and HLA-B*58:01 Genotype
- Amitriptyline Therapy and CYP2D6 and CYP2C19 Genotype
- Aripiprazole Therapy and CYP2D6 Genotype
- Atazanavir Therapy and UGT1A1 Genotype
- Atomoxetine Therapy and CYP2D6 Genotype
- Azathioprine Therapy and TPMT and NUDT15 Genotype
- Belinostat Therapy and UGT1A1 Genotype
- Brivaracetam Therapy and CYP2C19 Genotype
- Capecitabine Therapy and DPYD Genotype
- Carbamazepine Therapy and HLA Genotype
- Carisoprodol Therapy and CYP2C19 Genotype
- Carvedilol Therapy and CYP2D6 Genotype
- Celecoxib Therapy and CYP2C9 Genotype
- Cetuximab Therapy and RAS and BRAF Genotype
- Chloroquine Therapy and G6PD Genotype
- Clobazam Therapy and CYP2C19 Genotype
- Clopidogrel Therapy and CYP2C19 Genotype
- Clozapine Therapy and CYP Genotype
- Codeine Therapy and CYP2D6 Genotype
- Dabrafenib Therapy and BRAF Genotype
- Deutetrabenazine Therapy and CYP2D6 Genotype
- Diazepam Therapy and CYP2C19 Genotype
- Dronabinol Therapy and CYP2C9 Genotype
- Eliglustat Therapy and CYP2D6 Genotype
- Esomeprazole Therapy and CYP2C19 Genotype
- Flibanserin Therapy and CYP2C19 Genotype
- Fluorouracil Therapy and DPYD Genotype
- Flurbiprofen Therapy and CYP2C9 Genotype
- Gentamicin Therapy and MT-RNR1 Genotype
- Hydroxychloroquine Therapy and G6PD Genotype
- Imipramine Therapy and CYP2D6 and CYP2C19 Genotype
- Irinotecan Therapy and UGT1A1 Genotype
- Lacosamide Therapy and CYP2C19 Genotype
- Lecanemab Therapy and APOE Genotype
- Lesinurad Therapy and CYP2C9 Genotype
- Maraviroc Therapy and CCR5 Genotype
- Mercaptopurine Therapy and TPMT and NUDT15 Genotype
- Metoprolol Therapy and CYP2D6 Genotype
- Omeprazole Therapy and CYP2C19 Genotype
- Oxycodone Therapy and CYP2D6 Genotype
- Panitumumab Therapy and RAS and BRAF Genotype
- Pegloticase Therapy and G6PD Genotype
- Pertuzumab Therapy and ERBB2 Genotype
- Phenytoin Therapy and HLA-B*15:02 and CYP2C9 Genotype
- Piroxicam Therapy and CYP2C9 Genotype
- Prasugrel Therapy and CYP Genotype
- Primaquine Therapy and G6PD and CYP2D6 Genotype
- Propafenone Therapy and CYP2D6 Genotype
- Rasburicase Therapy and G6PD and CYB5R Genotype
- Risperidone Therapy and CYP2D6 Genotype
- Simeprevir Therapy and IFNL3 Genotype
- Simvastatin Therapy and SLCO1B1 Genotype
- Siponimod Therapy and CYP2C9 Genotype
- Sofosbuvir Therapy and IFNL4 Genotype
- Tafenoquine Therapy and G6PD Genotype
- Tamoxifen Therapy and CYP2D6 Genotype
- Thioguanine Therapy and TPMT and NUDT15 Genotype
- Thioridazine Therapy and CYP2D6 Genotypes
- Tramadol Therapy and CYP2D6 Genotype
- Trastuzumab Therapy and ERBB2 Genotype
- Valbenazine Therapy and CYP2D6 Genotype
- Vemurafenib Therapy and BRAF and NRAS Genotype
- Venlafaxine Therapy and CYP2D6 Genotype
- Voriconazole Therapy and CYP2C19 Genotype
- Warfarin Therapy and VKORC1 and CYP Genotype
Publication Details
Copyright
Copyright Notice
All Medical Genetics Summaries content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits copying, distribution, and adaptation of the work, provided the original work is properly cited and any changes from the original work are properly indicated. Any altered, transformed, or adapted form of the work may only be distributed under the same or similar license to this one.
Publisher
National Center for Biotechnology Information (US), Bethesda (MD)
NLM Citation
Pratt VM, Scott SA, Pirmohamed M, et al., editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012-. Genetic variants and drug responses.